{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:02:25Z","timestamp":1790928145739,"version":"4.1.0"},"reference-count":145,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T00:00:00Z","timestamp":1699315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Pfizer Pharmaceuticals Ltd.","award":["56288973"],"award-info":[{"award-number":["56288973"]}]},{"name":"Pfizer Pharmaceuticals Ltd.","award":["737.016.002"],"award-info":[{"award-number":["737.016.002"]}]},{"name":"Pfizer Pharmaceuticals Ltd.","award":["I00029"],"award-info":[{"award-number":["I00029"]}]},{"name":"NWO-BBOL","award":["56288973"],"award-info":[{"award-number":["56288973"]}]},{"name":"NWO-BBOL","award":["737.016.002"],"award-info":[{"award-number":["737.016.002"]}]},{"name":"NWO-BBOL","award":["I00029"],"award-info":[{"award-number":["I00029"]}]},{"DOI":"10.13039\/100016531","name":"ICI","doi-asserted-by":"publisher","award":["56288973"],"award-info":[{"award-number":["56288973"]}],"id":[{"id":"10.13039\/100016531","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016531","name":"ICI","doi-asserted-by":"publisher","award":["737.016.002"],"award-info":[{"award-number":["737.016.002"]}],"id":[{"id":"10.13039\/100016531","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016531","name":"ICI","doi-asserted-by":"publisher","award":["I00029"],"award-info":[{"award-number":["I00029"]}],"id":[{"id":"10.13039\/100016531","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>In Gaucher disease (GD), a relatively common sphingolipidosis, the mutant lysosomal enzyme acid \u03b2-glucocerebrosidase (GCase), encoded by the GBA1 gene, fails to properly hydrolyze the sphingolipid glucosylceramide (GlcCer) in lysosomes, particularly of tissue macrophages. As a result, GlcCer accumulates, which, to a certain extent, is converted to its deacylated form, glucosylsphingosine (GlcSph), by lysosomal acid ceramidase. The inability of mutant GCase to degrade GlcSph further promotes its accumulation. The amount of mutant GCase in lysosomes depends on the amount of mutant ER enzyme that shuttles to them. In the case of many mutant GCase forms, the enzyme is largely misfolded in the ER. Only a fraction correctly folds and is subsequently trafficked to the lysosomes, while the rest of the misfolded mutant GCase protein undergoes ER-associated degradation (ERAD). The retention of misfolded mutant GCase in the ER induces ER stress, which evokes a stress response known as the unfolded protein response (UPR). GD is remarkably heterogeneous in clinical manifestation, including the variant without CNS involvement (type 1), and acute and subacute neuronopathic variants (types 2 and 3). The present review discusses animal models developed to study the molecular and cellular mechanisms underlying GD.<\/jats:p>","DOI":"10.3390\/ijms242216035","type":"journal-article","created":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T11:23:39Z","timestamp":1699356219000},"page":"16035","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Animal Models for the Study of Gaucher Disease"],"prefix":"10.3390","volume":"24","author":[{"given":"Or","family":"Cabasso","sequence":"first","affiliation":[{"name":"Shmunis School of Biomedicine and Cancer Research, Faculty of Life Sciences, Tel Aviv University, Ramat Aviv 69978, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Kuppuramalingam","sequence":"additional","affiliation":[{"name":"Shmunis School of Biomedicine and Cancer Research, Faculty of Life Sciences, Tel Aviv University, Ramat Aviv 69978, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Lelieveld","sequence":"additional","affiliation":[{"name":"Leiden Institute of Chemistry, Leiden University, 9502 Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6458-1479","authenticated-orcid":false,"given":"Martijn","family":"Van der Lienden","sequence":"additional","affiliation":[{"name":"Leiden Institute of Chemistry, Leiden University, 9502 Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Boot","sequence":"additional","affiliation":[{"name":"Leiden Institute of Chemistry, Leiden University, 9502 Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8168-2565","authenticated-orcid":false,"given":"Johannes M.","family":"Aerts","sequence":"additional","affiliation":[{"name":"Leiden Institute of Chemistry, Leiden University, 9502 Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Horowitz","sequence":"additional","affiliation":[{"name":"Shmunis School of Biomedicine and Cancer Research, Faculty of Life Sciences, Tel Aviv University, Ramat Aviv 69978, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,11,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev.bi.60.070191.001353","article-title":"Lysosomal storage diseases","volume":"60","author":"Neufeld","year":"1991","journal-title":"Annu. Rev. Biochem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/sj.embor.embor873","article-title":"X-ray structure of human acid-beta-glucosidase, the defective enzyme in Gaucher disease","volume":"4","author":"Dvir","year":"2003","journal-title":"EMBO Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nchembio850","article-title":"Structure of acid beta-glucosidase with pharmacological chaperone provides insight into Gaucher disease","volume":"3","author":"Lieberman","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/cbic.200900142","article-title":"6-Amino-6-deoxy-5,6-di-N-(N\u2019-octyliminomethylidene)nojirimycin: Synthesis, biological evaluation, and crystal structure in complex with acid beta-glucosidase","volume":"10","author":"Brumshtein","year":"2009","journal-title":"Chembiochem"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"35351","DOI":"10.1074\/jbc.M114.593376","article-title":"A sensitive gel-based method combining distinct cyclophellitol-based probes for the identification of acid\/base residues in human retaining \u03b2-glucosidases","volume":"289","author":"Kallemeijn","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF00493387","article-title":"Immunocytochemical localization of sphingolipid activator protein-1, the sulfatide\/GM1 ganglioside activator, to lysosomes in human liver and colon","volume":"86","author":"Tamaru","year":"1986","journal-title":"Histochemistry"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"32438","DOI":"10.1074\/jbc.271.50.32438","article-title":"Biosynthesis, processing, and targeting of sphingolipid activator protein (SAP) precursor in cultured human fibroblasts. Mannose 6-phosphate receptor-independent endocytosis of SAP precursor","volume":"271","author":"Vielhaber","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"17312","DOI":"10.1074\/jbc.271.29.17312","article-title":"Proteolytic processing patterns of prosaposin in insect and mammalian cells","volume":"271","author":"Leonova","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0006-291X(05)80236-0","article-title":"Secretion of sphingolipid hydrolase activator precursor, prosaposin","volume":"176","author":"Hineno","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_10","first-page":"681","article-title":"Identification of the neurotrophic factor sequence of prosaposin","volume":"9","author":"Carson","year":"1995","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/s41593-021-00862-0","article-title":"Genome-wide CRISPRi\/a screens in human neurons link lysosomal failure to ferroptosis","volume":"24","author":"Tian","year":"2021","journal-title":"Nat. Neurosci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0022-2275(20)40540-1","article-title":"Saposins: Structure, function, distribution, and molecular genetics","volume":"33","author":"Kishimoto","year":"1992","journal-title":"J. Lipid Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1471-4159.2007.04709.x","article-title":"The function of sphingolipids in the nervous system: Lessons learnt from mouse models of specific sphingolipid activator protein deficiencies","volume":"103","author":"Matsuda","year":"2007","journal-title":"J. Neurochem."},{"key":"ref_14","first-page":"1252","article-title":"Correction of sulfatide metabolism after transfer of prosaposin cDNA to cultured cells from a patient with SAP-1 deficiency","volume":"50","author":"Rafi","year":"1992","journal-title":"Am. J. Hum. Genet."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ajmg.a.32712","article-title":"Prosaposin deficiency and saposin B deficiency (activator-deficient metachromatic leukodystrophy): Report on two patients detected by analysis of urinary sphingolipids and carrying novel PSAP gene mutations","volume":"149A","author":"Kuchar","year":"2009","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"9372","DOI":"10.1074\/jbc.M809457200","article-title":"Saposin B-dependent reconstitution of arylsulfatase A activity in vitro and in cell culture models of metachromatic leukodystrophy","volume":"284","author":"Matzner","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1073\/pnas.68.11.2810","article-title":"Gaucher\u2019s disease: Deficiency of \u2018acid\u2019-glucosidase and reconstitution of enzyme activity in vitro","volume":"68","author":"Ho","year":"1971","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1093\/hmg\/ddh281","article-title":"Mutation in saposin D domain of sphingolipid activator protein gene causes urinary system defects and cerebellar Purkinje cell degeneration with accumulation of hydroxy fatty acid-containing ceramide in mouse","volume":"13","author":"Matsuda","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0014-5793(91)80760-Z","article-title":"Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease","volume":"284","author":"Schnabel","year":"1991","journal-title":"FEBS Lett."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/hmg\/ddq204","article-title":"Saposin C mutations in Gaucher disease patients resulting in lysosomal lipid accumulation, saposin C deficiency, but normal prosaposin processing and sorting","volume":"19","author":"Vaccaro","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ymgme.2012.04.024","article-title":"The role of saposin C in Gaucher disease","volume":"106","author":"Tamargo","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1399-0004.2007.00899.x","article-title":"Non-neuronopathic Gaucher disease due to saposin C deficiency","volume":"72","author":"Czartoryska","year":"2007","journal-title":"Clin. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cell.2007.10.018","article-title":"LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase","volume":"131","author":"Reczek","year":"2007","journal-title":"Cell"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1093\/hmg\/ddn124","article-title":"A nonsense mutation in the LIMP-2 gene associated with progressive myoclonic epilepsy and nephrotic syndrome","volume":"17","author":"Balreira","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"ref_25","first-page":"3839","article-title":"Role of LIMP-2 in the intracellular trafficking of beta-glucosidase in different human cellular models","volume":"29","author":"Malini","year":"2015","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/hmg\/ddi240","article-title":"ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity","volume":"14","author":"Ron","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/hmg\/dds535","article-title":"ITCH regulates degradation of mutant glucocerebrosidase: Implications to Gaucher disease","volume":"22","author":"Maor","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1463-1326.2010.01281.x","article-title":"The unfolded protein response is required to maintain the integrity of the endoplasmic reticulum, prevent oxidative stress and preserve differentiation in beta-cells","volume":"12","author":"Kaufman","year":"2010","journal-title":"Diabetes Obes. Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0006-291X(65)90743-6","article-title":"Metabolism of Glucocerebrosides. Ii. Evidence of an Enzymatic Deficiency in Gaucher\u2019s Disease","volume":"18","author":"Brady","year":"1965","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0022-2275(20)36768-7","article-title":"Isolation and characterization of glucosylsphingosine from Gaucher\u2019s spleen","volume":"15","author":"Raghavan","year":"1974","journal-title":"J. Lipid Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20676","article-title":"Gaucher disease: Mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)","volume":"29","author":"Hruska","year":"2008","journal-title":"Hum. Mutat."},{"key":"ref_32","unstructured":"Aronson, S.M., and Volk, B.W. (1962). Cerebral Sphingolipidosis, Academic Press."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/qjmed\/89.9.691","article-title":"Occurrence of Parkinson\u2019s syndrome in type I Gaucher disease","volume":"89","author":"Neudorfer","year":"1996","journal-title":"QJM"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"F163","DOI":"10.1136\/fn.82.2.F163","article-title":"Type 2 Gaucher disease: The collodion baby phenotype revisited","volume":"82","author":"Stone","year":"2000","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1001\/archneur.1993.00540110088009","article-title":"The role of neurogenetics in Gaucher disease","volume":"50","author":"Brady","year":"1993","journal-title":"Arch. Neurol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1385\/MB:34:2:279","article-title":"The unfolded protein response","volume":"34","author":"Schroder","year":"2006","journal-title":"Mol. Biotechnol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1126\/science.1209038","article-title":"The unfolded protein response: From stress pathway to homeostatic regulation","volume":"334","author":"Walter","year":"2011","journal-title":"Science"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1515\/bchm2.1966.345.1.197","article-title":"Studies on the action mechanism of glycoside splitting anzymes, I. Presentation and properties of specific inhibitors","volume":"345","author":"Legler","year":"1966","journal-title":"Hoppe Seylers Z. Physiol. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0006-291X(75)90286-7","article-title":"The Gaucher mouse","volume":"67","author":"Kanfer","year":"1975","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1471-4159.1978.tb12395.x","article-title":"The Gaucher mouse: Differential action of conduritol B epoxide and reversibility of its effects","volume":"30","author":"Stephens","year":"1978","journal-title":"J. Neurochem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/mthe.2002.0650","article-title":"Demonstration of feasibility of in vivo gene therapy for Gaucher disease using a chemically induced mouse model","volume":"6","author":"Marshall","year":"2002","journal-title":"Mol. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nm.3449","article-title":"RIPK3 as a potential therapeutic target for Gaucher\u2019s disease","volume":"20","author":"Vitner","year":"2014","journal-title":"Nat. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/path.4751","article-title":"Delineating pathological pathways in a chemically induced mouse model of Gaucher disease","volume":"239","author":"Vardi","year":"2016","journal-title":"J. Pathol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1016\/j.celrep.2016.07.085","article-title":"Identification of Modifier Genes in a Mouse Model of Gaucher Disease","volume":"16","author":"Klein","year":"2016","journal-title":"Cell Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1651-2227.2007.00641.x","article-title":"Biomarkers for lysosomal storage disorders: Identification and application as exemplified by chitotriosidase in Gaucher disease","volume":"97","author":"Aerts","year":"2008","journal-title":"Acta Paediatr."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/2211-5463.12078","article-title":"Elevation of glycoprotein nonmetastatic melanoma protein B in type 1 Gaucher disease patients and mouse models","volume":"6","author":"Kramer","year":"2016","journal-title":"FEBS Open Bio"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/mt.2015.16","article-title":"Lentiviral gene therapy using cellular promoters cures type 1 Gaucher disease in mice","volume":"23","author":"Dahl","year":"2015","journal-title":"Mol. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Zigdon, H., Savidor, A., Levin, Y., Meshcheriakova, A., Schiffmann, R., and Futerman, A.H. (2015). Identification of a biomarker in cerebrospinal fluid for neuronopathic forms of Gaucher disease. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0120194"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2018.08.013","article-title":"The glycoprotein GPNMB is selectively elevated in the substantia nigra of Parkinson\u2019s disease patients and increases after lysosomal stress","volume":"120","author":"Moloney","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/hmg\/ddp061","article-title":"No evidence for activation of the unfolded protein response in neuronopathic models of Gaucher disease","volume":"18","author":"Vitner","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF03402150","article-title":"A chimeric mouse model of Gaucher disease","volume":"8","author":"Beutler","year":"2002","journal-title":"Mol. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/357407a0","article-title":"Animal model of Gaucher\u2019s disease from targeted disruption of the mouse glucocerebrosidase gene","volume":"357","author":"Tybulewicz","year":"1992","journal-title":"Nature"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0022-2275(20)40772-2","article-title":"beta-Glucocerebrosidase activity in murine epidermis: Characterization and localization in relation to differentiation","volume":"33","author":"Holleran","year":"1992","journal-title":"J. Lipid Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1096-7192(02)00117-8","article-title":"Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: Correlation with phenotype and genotype","volume":"76","author":"Orvisky","year":"2002","journal-title":"Mol. Genet. Metab."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3346\/jkms.2006.21.4.733","article-title":"Upregulation of proinflammatory cytokines in the fetal brain of the Gaucher mouse","volume":"21","author":"Hong","year":"2006","journal-title":"J. Korean Med. Sci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/emm.2006.41","article-title":"Downregulation of neurotrophic factors in the brain of a mouse model of Gaucher disease; implications for neuronal loss in Gaucher disease","volume":"38","author":"Kim","year":"2006","journal-title":"Exp. Mol. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature21368","article-title":"Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease","volume":"543","author":"Pandey","year":"2017","journal-title":"Nature"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"13819","DOI":"10.1073\/pnas.0606016103","article-title":"Effective cell and gene therapy in a murine model of Gaucher disease","volume":"103","author":"Enquist","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/path.4227","article-title":"B cell lymphoma and myeloma in murine Gaucher\u2019s disease","volume":"231","author":"Pavlova","year":"2013","journal-title":"J. Pathol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/path.4452","article-title":"Inhibition of UDP-glucosylceramide synthase in mice prevents Gaucher disease-associated B-cell malignancy","volume":"235","author":"Pavlova","year":"2015","journal-title":"J. Pathol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ymgme.2006.09.008","article-title":"Generation of a conditional knockout of murine glucocerebrosidase: Utility for the study of Gaucher disease","volume":"90","author":"Sinclair","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.expneurol.2010.07.023","article-title":"Intracerebroventricular delivery of glucocerebrosidase reduces substrates and increases lifespan in a mouse model of neuronopathic Gaucher disease","volume":"225","author":"Bercury","year":"2010","journal-title":"Exp. Neurol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Cabrera-Salazar, M.A., Deriso, M., Bercury, S.D., Li, L., Lydon, J.T., Weber, W., Pande, N., Cromwell, M.A., Copeland, D., and Leonard, J. (2012). Systemic delivery of a glucosylceramide synthase inhibitor reduces CNS substrates and increases lifespan in a mouse model of type 2 Gaucher disease. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0043310"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"17483","DOI":"10.1073\/pnas.0708086104","article-title":"Murine models of acute neuronopathic Gaucher disease","volume":"104","author":"Enquist","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/hmg\/ddr019","article-title":"Spatial and temporal correlation between neuron loss and neuroinflammation in a mouse model of neuronopathic Gaucher disease","volume":"20","author":"Vitner","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/brain\/aws095","article-title":"Contribution of brain inflammation to neuronal cell death in neuronopathic forms of Gaucher\u2019s disease","volume":"135","author":"Vitner","year":"2012","journal-title":"Brain"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"19473","DOI":"10.1073\/pnas.1003308107","article-title":"Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage","volume":"107","author":"Mistry","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0925-4439(93)90090-N","article-title":"Demonstration of the existence of a second, non-lysosomal glucocerebrosidase that is not deficient in Gaucher disease","volume":"1181","author":"Brandsma","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1172\/JCI29224","article-title":"Mutation of beta-glucosidase 2 causes glycolipid storage disease and impaired male fertility","volume":"116","author":"Yildiz","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1074\/jbc.M610544200","article-title":"Identification of the non-lysosomal glucosylceramidase as beta-glucosidase 2","volume":"282","author":"Boot","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1194\/jlr.M064923","article-title":"Glucosylated cholesterol in mammalian cells and tissues: Formation and degradation by multiple cellular beta-glucosidases","volume":"57","author":"Marques","year":"2016","journal-title":"J. Lipid Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1073\/pnas.1400768111","article-title":"Glucocerebrosidase 2 gene deletion rescues type 1 Gaucher disease","volume":"111","author":"Mistry","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Pewzner-Jung, Y., Joseph, T., Blumenreich, S., Vardi, A., Ferreira, N.S., Cho, S.M., Eilam, R., Tsoory, M., Biton, I.E., and Brumfeld, V. (2021). Brain pathology and cerebellar purkinje cell loss in a mouse model of chronic neuronopathic Gaucher disease. Prog. Neurobiol., 197.","DOI":"10.1016\/j.pneurobio.2020.101939"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e79830","DOI":"10.7554\/eLife.79830","article-title":"Neuroinflammation in neuronopathic Gaucher disease: Role of microglia and NK cells, biomarkers, and response to substrate reduction therapy","volume":"11","author":"Boddupalli","year":"2022","journal-title":"eLife"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1073\/pnas.95.5.2503","article-title":"Mice with type 2 and 3 Gaucher disease point mutations generated by a single insertion mutagenesis procedure","volume":"95","author":"Liu","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJM198703053161002","article-title":"A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher\u2019s disease","volume":"316","author":"Tsuji","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0378-1119(90)90264-R","article-title":"Prevalent and rare mutations among Gaucher patients","volume":"96","author":"Eyal","year":"1990","journal-title":"Gene"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1172\/JCI0214530","article-title":"Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage","volume":"109","author":"Mizukami","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0002-9440(10)63566-3","article-title":"Viable mouse models of acid beta-glucosidase deficiency: The defect in Gaucher disease","volume":"163","author":"Xu","year":"2003","journal-title":"Am. J. Pathol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"12101","DOI":"10.1073\/pnas.1108197108","article-title":"CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy","volume":"108","author":"Sardi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Xu, Y.H., Sun, Y., Barnes, S., and Grabowski, G.A. (2010). Comparative therapeutic effects of velaglucerase alfa and imiglucerase in a Gaucher disease mouse model. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0010750"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Xu, Y.H., Jia, L., Quinn, B., Zamzow, M., Stringer, K., Aronow, B., Sun, Y., Zhang, W., Setchell, K.D., and Grabowski, G.A. (2011). Global gene expression profile progression in Gaucher disease mouse models. BMC Genom., 12.","DOI":"10.1186\/1471-2164-12-20"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ymgme.2007.04.001","article-title":"A specific and potent inhibitor of glucosylceramide synthase for substrate inhibition therapy of Gaucher disease","volume":"91","author":"McEachern","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10545-010-9072-z","article-title":"Improved management of lysosomal glucosylceramide levels in a mouse model of type 1 Gaucher disease using enzyme and substrate reduction therapy","volume":"33","author":"Marshall","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/hmg\/ddp580","article-title":"Neuronopathic Gaucher disease in the mouse: Viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits","volume":"19","author":"Sun","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/mt.2016.53","article-title":"CNS-accessible Inhibitor of Glucosylceramide Synthase for Substrate Reduction Therapy of Neuronopathic Gaucher Disease","volume":"24","author":"Marshall","year":"2016","journal-title":"Mol. Ther."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1111\/j.1742-4658.2006.05410.x","article-title":"Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients","volume":"273","author":"Chang","year":"2006","journal-title":"FEBS J."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.bcp.2006.12.015","article-title":"Selective action of the iminosugar isofagomine, a pharmacological chaperone for mutant forms of acid-beta-glucosidase","volume":"73","author":"Steet","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1002\/cbic.200800249","article-title":"Isofagomine induced stabilization of glucocerebrosidase","volume":"9","author":"Kornhaber","year":"2008","journal-title":"Chembiochem"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1742-4658.2010.07588.x","article-title":"The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of beta-glucosidase","volume":"277","author":"Khanna","year":"2010","journal-title":"FEBS J."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Sun, Y., Ran, H., Liou, B., Quinn, B., Zamzow, M., Zhang, W., Bielawski, J., Kitatani, K., Setchell, K.D., and Hannun, Y.A. (2011). Isofagomine in vivo effects in a neuronopathic Gaucher disease mouse. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0019037"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1002\/cpet.19","article-title":"Zebrafish: Development of a Vertebrate Model Organism","volume":"16","author":"Meyers","year":"2018","journal-title":"Curr. Protoc. Essent. Lab. Tech."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/aja.1002030302","article-title":"Stages of embryonic development of the zebrafish","volume":"203","author":"Kimmel","year":"1995","journal-title":"Dev. Dyn."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0531-5565(02)00088-8","article-title":"Life spans and senescent phenotypes in two strains of Zebrafish (Danio rerio)","volume":"37","author":"Gerhard","year":"2002","journal-title":"Exp. Gerontol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature12111","article-title":"The zebrafish reference genome sequence and its relationship to the human genome","volume":"496","author":"Howe","year":"2013","journal-title":"Nature"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1177\/0192623311409597","article-title":"Normal anatomy and histology of the adult zebrafish","volume":"39","author":"Menke","year":"2011","journal-title":"Toxicol. Pathol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0012-1606(02)00083-0","article-title":"Windows into development: Historic, current, and future perspectives on transgenic zebrafish","volume":"256","author":"Udvadia","year":"2003","journal-title":"Dev. Biol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/bs.mcb.2016.01.009","article-title":"Contemporary zebrafish transgenesis with Tol2 and application for Cre\/lox recombination experiments","volume":"135","author":"Felker","year":"2016","journal-title":"Methods Cell Biol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1021\/jacs.9b00056","article-title":"Functionalized Cyclophellitols Are Selective Glucocerebrosidase Inhibitors and Induce a Bona Fide Neuropathic Gaucher Model in Zebrafish","volume":"141","author":"Artola","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nchembio.466","article-title":"Ultrasensitive in situ visualization of active glucocerebrosidase molecules","volume":"6","author":"Witte","year":"2010","journal-title":"Nat. Chem. Biol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/bs.mie.2017.06.039","article-title":"Activity-Based Probes for Glycosidases: Profiling and Other Applications","volume":"598","author":"Kuo","year":"2018","journal-title":"Methods Enzym."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1242\/dev.001115","article-title":"Controlling morpholino experiments: Don\u2019t stop making antisense","volume":"135","author":"Eisen","year":"2008","journal-title":"Development"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cca.2017.01.014","article-title":"Simultaneous quantitation of sphingoid bases by UPLC-ESI-MS\/MS with identical (13)C-encoded internal standards","volume":"466","author":"Mirzaian","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1194\/jlr.RA119000154","article-title":"Role of beta-glucosidase 2 in aberrant glycosphingolipid metabolism: Model of glucocerebrosidase deficiency in zebrafish","volume":"60","author":"Lelieveld","year":"2019","journal-title":"J. Lipid Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/hmg\/ddu538","article-title":"Glucocerebrosidase deficiency in zebrafish affects primary bone ossification through increased oxidative stress and reduced Wnt\/beta-catenin signaling","volume":"24","author":"Zancan","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm3486","article-title":"TALENs: A widely applicable technology for targeted genome editing","volume":"14","author":"Joung","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"6640","DOI":"10.1093\/hmg\/ddv369","article-title":"Glucocerebrosidase 1 deficient Danio rerio mirror key pathological aspects of human Gaucher disease and provide evidence of early microglial activation preceding alpha-synuclein-independent neuronal cell death","volume":"24","author":"Keatinge","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/1873-3468.12104","article-title":"Lysosomal glycosphingolipid catabolism by acid ceramidase: Formation of glycosphingoid bases during deficiency of glycosidases","volume":"590","author":"Ferraz","year":"2016","journal-title":"FEBS Lett."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"100199","DOI":"10.1016\/j.jlr.2022.100199","article-title":"Consequences of excessive glucosylsphingosine in glucocerebrosidase-deficient zebrafish","volume":"63","author":"Lelieveld","year":"2022","journal-title":"J. Lipid Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"e2217673120","DOI":"10.1073\/pnas.2217673120","article-title":"Gaucher disease protects against tuberculosis","volume":"120","author":"Fan","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_111","first-page":"181","article-title":"Beyond the zebrafish: Diverse fish species for modeling human disease","volume":"7","author":"Schartl","year":"2014","journal-title":"Dis. Models Mech."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/bs.mcb.2016.09.001","article-title":"Small teleost fish provide new insights into human skeletal diseases","volume":"138","author":"Witten","year":"2017","journal-title":"Methods Cell Biol."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Bajoghli, B., Dick, A.M., Claasen, A., Doll, L., and Aghaallaei, N. (2019). Zebrafish and Medaka: Two Teleost Models of T-Cell and Thymic Development. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20174179"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ydbio.2019.07.009","article-title":"Zebrafish and medaka as models for biomedical research of bone diseases","volume":"457","author":"Winkler","year":"2020","journal-title":"Dev. Biol."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Uemura, N., Koike, M., Ansai, S., Kinoshita, M., Ishikawa-Fujiwara, T., Matsui, H., Naruse, K., Sakamoto, N., Uchiyama, Y., and Todo, T. (2015). Viable neuronopathic Gaucher disease model in Medaka (Oryzias latipes) displays axonal accumulation of alpha-synuclein. PLoS Genet., 11.","DOI":"10.1371\/journal.pgen.1005065"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13041-021-00790-x","article-title":"Impact of Gba2 on neuronopathic Gaucher\u2019s disease and alpha-synuclein accumulation in medaka (Oryzias latipes)","volume":"14","author":"Nakanishi","year":"2021","journal-title":"Mol. Brain"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1101\/gr.169101","article-title":"A systematic analysis of human disease-associated gene sequences in Drosophila melanogaster","volume":"11","author":"Reiter","year":"2001","journal-title":"Genome Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1126\/science.287.5461.2185","article-title":"The genome sequence of Drosophila melanogaster","volume":"287","author":"Adams","year":"2000","journal-title":"Science"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1242\/dmm.023762","article-title":"Drosophila tools and assays for the study of human diseases","volume":"9","author":"Ugur","year":"2016","journal-title":"Dis. Models Mech."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Wagner, C., Isermann, K., Fehrenbach, H., and Roeder, T. (2008). Molecular architecture of the fruit fly\u2019s airway epithelial immune system. BMC Genom., 9.","DOI":"10.1186\/1471-2164-9-446"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.conb.2014.03.001","article-title":"Shared mechanisms between Drosophila peripheral nervous system development and human neurodegenerative diseases","volume":"27","author":"Charng","year":"2014","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1242\/dmm.003970","article-title":"Drosophila melanogaster as a model for human intestinal infection and pathology","volume":"4","author":"Apidianakis","year":"2011","journal-title":"Dis. Models Mech."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1534\/genetics.104.026427","article-title":"The BDGP gene disruption project: Single transposon insertions associated with 40% of Drosophila genes","volume":"167","author":"Bellen","year":"2004","journal-title":"Genetics"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.celrep.2013.06.020","article-title":"Highly efficient targeted mutagenesis of Drosophila with the CRISPR\/Cas9 system","volume":"4","author":"Bassett","year":"2013","journal-title":"Cell Rep."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nature05954","article-title":"A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila","volume":"448","author":"Dietzl","year":"2007","journal-title":"Nature"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1242\/dev.118.2.401","article-title":"Targeted gene expression as a means of altering cell fates and generating dominant phenotypes","volume":"118","author":"Brand","year":"1993","journal-title":"Development"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/gene.10150","article-title":"GAL4 system in Drosophila: A fly geneticist\u2019s Swiss army knife","volume":"34","author":"Duffy","year":"2002","journal-title":"Genesis"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1534\/genetics.115.183392","article-title":"Genetics on the Fly: A Primer on the Drosophila Model System","volume":"201","author":"Hales","year":"2015","journal-title":"Genetics"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1534\/genetics.117.199950","article-title":"A Short History and Description of Drosophila melanogaster Classical Genetics: Chromosome Aberrations, Forward Genetic Screens, and the Nature of Mutations","volume":"206","author":"Kaufman","year":"2017","journal-title":"Genetics"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Cabasso, O., Paul, S., Dorot, O., Maor, G., Krivoruk, O., Pasmanik-Chor, M., Mirzaian, M., Ferraz, M., Aerts, J., and Horowitz, M. (2019). Drosophila melanogaster Mutated in its GBA1b Ortholog Recapitulates Neuronopathic Gaucher Disease. J. Clin. Med., 8.","DOI":"10.3390\/jcm8091420"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Cabasso, O., Paul, S., Maor, G., Pasmanik-Chor, M., Kallemeijn, W., Aerts, J., and Horowitz, M. (2021). The Uncovered Function of the Drosophila GBA1a-Encoded Protein. Cells, 10.","DOI":"10.3390\/cells10030630"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1080\/15384101.2017.1380134","article-title":"Death by over-eating: The Gaucher disease associated gene GBA1, identified in a screen for mediators of autophagic cell death, is necessary for developmental cell death in Drosophila midgut","volume":"16","author":"Dasari","year":"2017","journal-title":"Cell Cycle"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"11654","DOI":"10.1523\/JNEUROSCI.4527-15.2016","article-title":"A Drosophila Model of Neuronopathic Gaucher Disease Demonstrates Lysosomal-Autophagic Defects and Altered mTOR Signalling and Is Functionally Rescued by Rapamycin","volume":"36","author":"Kinghorn","year":"2016","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Davis, M.Y., Trinh, K., Thomas, R.E., Yu, S., Germanos, A.A., Whitley, B.N., Sardi, S.P., Montine, T.J., and Pallanck, L.J. (2016). Glucocerebrosidase Deficiency in Drosophila Results in alpha-Synuclein-Independent Protein Aggregation and Neurodegeneration. PLoS Genet., 12.","DOI":"10.1371\/journal.pgen.1005944"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Atilano, M.L., Hull, A., Romila, C.-A., Adams, M.L., Wildfire, J., Ure\u00f1a, E., Dyson, M., Ivan-Castillo-Quan, J., Partridge, L., and Kinghorn, K.J. (2022). Gba1 deletion causes immune hyperactivation and microbial dysbiosis through autophagic defects. bioRxiv.","DOI":"10.1101\/2022.12.15.520449"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.gene.2017.03.004","article-title":"Minos-insertion mutant of the Drosophila GBA gene homologue showed abnormal phenotypes of climbing ability, sleep and life span with accumulation of hydroxy-glucocerebroside","volume":"614","author":"Kawasaki","year":"2017","journal-title":"Gene"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"E1752","DOI":"10.1073\/pnas.1306220110","article-title":"Dnr1 mutations cause neurodegeneration in Drosophila by activating the innate immune response in the brain","volume":"110","author":"Cao","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"23502","DOI":"10.1074\/jbc.M109.012393","article-title":"Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease","volume":"284","author":"Maegawa","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/030098587301000302","article-title":"Neurovisceral glucocerebroside storage (Gaucher\u2019s disease) in a dog","volume":"10","author":"Hartley","year":"1973","journal-title":"Vet. Pathol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/icb.1979.56","article-title":"Canine Gaucher disease--the enzymic defect","volume":"57","author":"Jolly","year":"1979","journal-title":"Aust. J. Exp. Biol. Med. Sci."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10545-010-9230-3","article-title":"Gaucher disease in sheep","volume":"34","author":"Karageorgos","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/age.12613","article-title":"A nucleotide substitution in exon 8 of the glucosylceramidase beta gene is associated with Gaucher disease in sheep","volume":"48","author":"Zhou","year":"2017","journal-title":"Anim. Genet."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.nbd.2016.03.011","article-title":"Glycosphingolipid analysis in a naturally occurring ovine model of acute neuronopathic Gaucher disease","volume":"91","author":"Karageorgos","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ymgme.2017.05.010","article-title":"Lipid composition of microdomains is altered in neuronopathic Gaucher disease sheep brain and spleen","volume":"121","author":"Hein","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Winner, L.K., Beard, H., Karageorgos, L., Smith, N.J., Hopwood, J.J., and Hemsley, K.M. (2023). The ovine Type II Gaucher disease model recapitulates aspects of human brain disease. Biochim. Biophys. Acta Mol. Basis Dis., 1869.","DOI":"10.1016\/j.bbadis.2023.166658"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/22\/16035\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:18:42Z","timestamp":1760131122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/22\/16035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,7]]},"references-count":145,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["ijms242216035"],"URL":"https:\/\/doi.org\/10.3390\/ijms242216035","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,7]]}}}